Supernus Pharmaceuticals | SUPN - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Abbott USD 5.86B 675M 2026-03
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Aurora Cannabis CAD 29.79M 16.83M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Canopy Growth CAD 8.26M 13.2M 2026-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Eisai JPY 153.41B 15.44B 2026-03
Eli Lilly USD 15.92B 1.33B 2025-12
Novo Nordisk DKK 64.01B 1.19B 2025-06
Pacira USD 126.64M 15.61M 2026-03
Perrigo USD 325.5M 36.7M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
United Therapeutics USD 315.5M 286.6M 2025-12
Xeris Pharmaceuticals USD 72.55M 404K 2026-03